PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for pseudoephedrine hydrochloride; triprolidine hydrochloride and what is the scope of patent protection?
Pseudoephedrine hydrochloride; triprolidine hydrochloride
is the generic ingredient in twelve branded drugs marketed by Glaxosmithkline, Kv Pharm, Cenci, Usl Pharma, Newtron Pharms, Pvt Form, Chartwell Rx, Sandoz, Teva, Watson Labs, West Ward, Ivax Sub Teva Pharms, and Superpharm, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.Summary for PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 12 |
| Applicants: | 13 |
| NDAs: | 16 |
| Patent Applications: | 33 |
| DailyMed Link: | PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
US Patents and Regulatory Information for PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088193-001 | May 17, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pvt Form | ALLERFED | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088860-001 | Jan 31, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| West Ward | TRIPROLIDINE AND PSEUDOEPHEDRINE | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088117-001 | Apr 19, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kv Pharm | TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES | pseudoephedrine hydrochloride; triprolidine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 071798-001 | Mar 16, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cenci | HISTAFED | pseudoephedrine hydrochloride; triprolidine hydrochloride | SYRUP;ORAL | 088283-001 | Apr 20, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | TRIPHED | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088630-001 | May 17, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
